# A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,

> **NCT00868309** · PHASE2 · COMPLETED · sponsor: **Instituto Bioclon S.A. de C.V.** · enrollment: 12 (actual)

## Conditions studied

- Snake Bite
- Blood Coagulation Disorders

## Interventions

- **BIOLOGICAL:** Anavip
- **BIOLOGICAL:** CroFab

## Key facts

- **NCT ID:** NCT00868309
- **Lead sponsor:** Instituto Bioclon S.A. de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-08
- **Final completion:** 2007-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868309, "A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00868309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*